McKesson (MCK)

NYSE Market Closed

McKesson Corporation is a major healthcare services and distribution company that plays a central role in the pharmaceutical supply chain. Its core business is sourcing, warehousing, and distributing prescription medicines, including branded drugs, generics, and specialty therapies, to pharmacies, hospitals, health systems, physician offices, and other care providers. In the United States, McKesson is one of the three large drug wholesalers that together handle the vast majority of pharmaceutical distribution, making the company an important infrastructure provider for the healthcare market.

The company’s scale allows it to manage high-volume, low-margin distribution efficiently while helping manufacturers reach healthcare customers and helping pharmacies maintain reliable access to medicines. McKesson serves large retail pharmacy chains, independent pharmacies, mail-order providers, and institutional healthcare customers. It also has operations in Canada, where it participates in pharmaceutical distribution and related healthcare services.

Beyond drug wholesaling, McKesson supplies medical-surgical products, equipment, and practice support to healthcare providers. Its offerings extend into oncology and specialty care services, pharmacy technology, clinical workflow tools, and data-driven solutions that support prescribing, reimbursement, inventory management, and patient access. These adjacent businesses help deepen its relationships across the healthcare system and diversify its sources of revenue.

McKesson’s performance is closely tied to prescription volumes, drug pricing dynamics, manufacturer relationships, and the growth of specialty medicines. The company also operates in a highly regulated environment, with ongoing exposure to compliance requirements, reimbursement pressure, and public scrutiny of pharmaceutical distribution. Its competitive position rests on logistics scale, customer relationships, technology capabilities, and reliability in moving essential medicines through a complex healthcare supply chain.

739.53 USD
726.55 USD
+2.75 (+0.37%)
After-hours

Last updated

Market Cap
88.56B
P/E
18.6
P/FCF
15.49
P/S
0.22
Enterprise Value
91.11B
Sector
Health Care
Industry
Drugs, Drug Proprietaries, and Druggists' Sundries
Address
6555 STATE HIGHWAY 161, IRVING, TX, 75039
GlobeNewswire Inc.

$663.3 Bn Revenue Cycle Management Market Trends and Global Forecasts Report 2026-2035

21 May 2026, 09:57 AM
GlobeNewswire Inc.

Global Healthcare Analytics Market is Predicted to Cross the USD 380 Billion Mark by 2034 | DelveInsight

06 May 2026, 18:00 PM
GlobeNewswire Inc.

Robotic Pharmacy Prescription Market Research and Global Forecast Report 2025-2032

09 Apr 2026, 09:57 AM
GlobeNewswire Inc.

Biopharmaceutical Third Party Logistics (Distribution Management, Packaging & Labeling, Transportation, Warehousing) Market Research and Global Forecast Report 2026-2032

09 Apr 2026, 09:49 AM
GlobeNewswire Inc.

Evolve Founder Shayla King Opens Enrollment for The Performance + Happiness Lab to Help Senior Leaders Pursue Pay and Promotion

31 Mar 2026, 05:57 AM
GlobeNewswire Inc.

Cardiology EHR: The Digital Pulse Behind a USD 5.44 Billion Cardiac Care Evolution by 2035

20 Feb 2026, 15:00 PM
GlobeNewswire Inc.

AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies

12 Jan 2026, 15:00 PM
GlobeNewswire Inc.

Automated Pharmacy Compounding Systems Market Growing Toward USD 5.27 Billion in 2035

05 Dec 2025, 16:00 PM
GlobeNewswire Inc.

Iterum Therapeutics Provides Business Update

05 Dec 2025, 14:00 PM
GlobeNewswire Inc.

Healthcare Supply Chain Management Market Grows at 11.05% CAGR by 2034

14 Oct 2025, 16:00 PM
GlobeNewswire Inc.

AI in Medical Billing Market Size to Surpass USD 22.46 Billion by 2032, Owing to the Rising Demand for Automation, Accuracy, and Regulatory Compliance in Healthcare | Research by SNS Insider

21 Aug 2025, 07:57 AM
GlobeNewswire Inc.

Synergy CHC Corp Reports Second Quarter 2025 Financial Results and its Tenth Consecutive Quarter of Profitability

14 Aug 2025, 13:00 PM
Investing.com

These 5 Dividend Growers Are Outperforming the Market in Total Return

06 Aug 2025, 22:08 PM
GlobeNewswire Inc.

Cell and Gene Therapy Third-Party Logistics Market Forecast and Company Analysis Report 2025-2033 Featuring Cencora, Cardinal Health, McKesson, EVERSANA, Knipper Health, Arvato, DHL, and Kuehne+Nagel

28 Jul 2025, 11:57 AM
GlobeNewswire Inc.

Pharmacy Automation Market Surges with 10.12% CAGR; AI & Retail Pharmacy Demand Transform Dispensing in 2025

21 Jul 2025, 15:00 PM
GlobeNewswire Inc.

Cardiovascular Information System Market to Reach USD 2.8 Billion by 2032, Driven by Digital Health Advancements and Growing Cardiac Care Needs – SNS Insider

29 Jun 2025, 19:15 PM
GlobeNewswire Inc.

U.S. Revenue Cycle Management (Integrated, Standalone) Market Trends Analysis Report 2025-2030 | Digital Transformation, Strategic Collaborations, and Regulatory Shifts Drive Growth

19 Jun 2025, 16:51 PM
Investing.com

3 Dividend Stocks Built for Stability as Growth Trades Cool Off

14 Apr 2025, 19:40 PM
GlobeNewswire Inc.

Radiology Information System Market Forecast Report and Company Analysis 2025-2033 Featuring Koninklijke Philips, Siemens Healthcare, Oracle, McKesson, GE, Fujifilm, Shimadzu, Hologic, Sectra

02 Apr 2025, 09:44 AM
GlobeNewswire Inc.

Global Healthcare Mobility Solutions Market to Exhibit Tremendous Growth at a CAGR of ~21% by 2032 | DelveInsight

04 Mar 2025, 19:00 PM
Market Cap
88.56B
Enterprise Value
91.11B
P/E
18.6
P/B
-40.78
P/S
0.22
EV / EBITDA
12.68
EV / Sales
0.23
EPS
39.62
Dividend Yield
0.43%
P/FCF
15.49
P/CF
14.39
Free Cash Flow
5.72B
ROE
-219.24%
ROA
5.78%
Debt / Equity
-3
Current Ratio
0.85
Quick Ratio
0.49
Cash
0.06
Avg Volume
1.31M
Fundamentals Snapshot Price
736.78

Income Statement

Line Item 2026 Q4 2026 Q3 2026 Q2 2026 Q1 2025 Q4
Revenue 96.3B 106.16B 103.15B 97.83B 90.82B
Gross profit 4.04B 3.69B 3.54B 3.28B 3.64B
Operating income 2.15B 1.62B 1.41B 1.04B 1.59B
EBITDA 2.44B 1.84B 1.66B 1.24B 1.82B
Net income 1.68B 1.19B 1.11B 784M 1.26B
Basic EPS 13.82 9.59 8.95 6.28 10.06
Diluted EPS 13.55 9.63 8.92 6.25 9.84

Balance Sheet

Line Item 2026 Q4 2026 Q3 2026 Q2 2026 Q1 2025 Q4
Total assets 82.32B 84.19B 84.16B 81.31B 75.14B
Total liabilities 83.16B 84.29B 84.74B 82.17B 76.83B
Total equity -1.78B -901M -1.36B -1.59B -1.69B
Cash & equivalents 3.98B 2.96B 4B 2.42B 5.69B
Current assets 57.21B 59.7B 59.89B 56.8B 55.4B
Current liabilities 67.02B 68.13B 68.03B 64.33B 61.6B

Cash Flow

Line Item 2026 Q4 2026 Q3 2026 Q2 2026 Q1 2025 Q4
Operating cash flow 3.42B 1.23B 2.42B -918M 7.75B
Investing cash flow 425M -269M -24M -3.56B -224M
Financing cash flow -2.82B -2.03B -961M 1.18B -2.86B
Change in cash 1.02B -1.06B 1.43B -3.27B 4.67B
Kind Filing Date Link
edgar index 3 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 144 — MCKESSON CORP View Filing
edgar index 144 — MCKESSON CORP View Filing
edgar index SD — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 144 — MCKESSON CORP View Filing
edgar index 144 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
edgar index 4 — MCKESSON CORP View Filing
form 4 Form 4 — TYLER BRIAN S. View Filing
form 4 Form 4 — TYLER BRIAN S. View Filing
form 4 Form 4 — TYLER BRIAN S. View Filing
form 4 Form 4 — TYLER BRIAN S. View Filing
form 4 Form 4 — Vitalone Britt J. View Filing
form 4 Form 4 — Vitalone Britt J. View Filing
form 4 Form 4 — Vitalone Britt J. View Filing
form 4 Form 4 — Vitalone Britt J. View Filing
form 4 Form 4 — Smith LeAnn B View Filing
form 4 Form 4 — Smith LeAnn B View Filing
form 4 Form 4 — Smith LeAnn B View Filing
form 4 Form 4 — Rodgers Thomas L View Filing
form 4 Form 4 — Rodgers Thomas L View Filing
form 4 Form 4 — Rodgers Thomas L View Filing
form 4 Form 4 — Rutledge Napoleon B JR View Filing
form 4 Form 4 — Rutledge Napoleon B JR View Filing
form 4 Form 4 — Rutledge Napoleon B JR View Filing
form 4 Form 4 — Lau Michele View Filing
form 4 Form 4 — Lau Michele View Filing
form 4 Form 4 — Lau Michele View Filing
form 4 Form 4 — Lau Michele View Filing
form 4 Form 4 — Fraga Francisco View Filing
form 4 Form 4 — Fraga Francisco View Filing
form 4 Form 4 — Fraga Francisco View Filing
form 4 Form 4 — Fraga Francisco View Filing
form 4 Form 4 — Fraga Francisco View Filing
form 4 Form 4 — Fraga Francisco View Filing
form 4 Form 4 — Fraga Francisco View Filing
form 4 Form 4 — Fraga Francisco View Filing
form 4 Form 4 — Rutledge Napoleon B JR View Filing
form 4 Form 4 — Rutledge Napoleon B JR View Filing
form 4 Form 4 — Rutledge Napoleon B JR View Filing
form 4 Form 4 — Lau Michele View Filing
form 4 Form 4 — Lau Michele View Filing
form 4 Form 4 — Lau Michele View Filing
form 4 Form 4 — Lau Michele View Filing
form 4 Form 4 — Rodgers Thomas L View Filing
form 4 Form 4 — Rodgers Thomas L View Filing
form 4 Form 4 — Rodgers Thomas L View Filing
form 4 Form 4 — Smith LeAnn B View Filing